XML 23 R14.htm IDEA: XBRL DOCUMENT v3.19.1
STOCKHOLDERS DEFICIT
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Note 8 - STOCKHOLDERS DEFICIT

Common stock returned by a director or officer

 

On March 13, 2019, a former Company director voluntarily returned 4,555,918 shares of Company common stock to Treasury. 

 

Shares to be issued

 

As of December 31, 2018, the Company had not yet issued 3,964,352 shares of common stock with a value of $243,839 for past services provided and an acquisition.  During the three months ended March 31, 2019, the Company was obligated to issue an additional 60,000 shares of common, valued at $184, per the terms of a consulting agreement (see Note 4), and 1,000,000 shares of common stock valued at $3,500, as consideration for amending an existing convertible note.  As of March 31, 2019, the Company had not yet issued 5,024,352 shares of common stock with a value of $247,523. 

 

Warrants

 

A summary of warrants for the year ended December 31, 2018, is as follows: 

 

          Weighted  
    Number     Average  
    of     Exercise  
    Warrants     Price  
Balance outstanding, December 31, 2018     8,004,708       0.014  
Warrants granted     -       -  
Warrants exercised     -       -  
Warrants expired or forfeited     -       -  
Balance outstanding, March 31, 2019     8,004,708     $ 0.014  
Balance exercisable, March 31, 2019     8,004,708     $ 0.014  

 

Information relating to outstanding warrants at March 31, 2019, summarized by exercise price, is as follows: 

 

        Outstanding     Exercisable  
                    Weighted           Weighted  
  Exercise Price Per                 Average           Average  
  Share     Shares     Life (Years)     Exercise Price     Shares     Exercise Price  
                                               
  $ 0.010 - 0.015       8,004,708       1.69     $ 0.014       8,004,708     $ 0.014  

 

The weighted-average remaining contractual life of warrants outstanding and exercisable at March 31, 2019 is 1.89 years. Both the outstanding and exercisable warrants outstanding at March 31, 2019 had no intrinsic value.